Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

The global pandemic of coronavirus disease 2019 (COVID‐19) is associated with the development of acute respiratory distress syndrome (ARDS), which requires ventilation in critically ill patients. The pathophysiology of ARDS results from acute inflammation within the alveolar space and prevention of...

Descripción completa

Detalles Bibliográficos
Autores principales: Whyte, Claire S., Morrow, Gael B., Mitchell, Joanne L., Chowdary, Pratima, Mutch, Nicola J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264738/
https://www.ncbi.nlm.nih.gov/pubmed/32329246
http://dx.doi.org/10.1111/jth.14872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264738/
https://www.ncbi.nlm.nih.gov/pubmed/32329246
http://dx.doi.org/10.1111/jth.14872

Ejemplares similares